Cannabis – the drug with history and future: scope of the problem, characteristics of the action and organ damages
Keywords:
cannabis, cannabinoids, drug addiction, organ damages from cannabisAbstract
Addiction to different psychoactive substances is one of the greatest challenges in front of the contemporary society. According to the latest data, cannabis is the most widely misused drug worldwide. Its action on different organs and systems is profoundly studied, despite which the misuse of cannabinoids is still considered to be connected with slight effects on human health. The present work has the aim to review the latest data connected with large-scale trials on the mechanism of action of cannabinoids and the organ damages caused by them, since the knowledge acquired from reliable sources is the first step in the recognition and coping with the problem.
References
World Drug Report 2025.
Годишен доклад по проблемите на наркоманиите в Европа, 2025.
Годишен доклад по проблемите на наркоманиите в Европа, 2017.
Даскалов P. Дрогите. Гуфо, 2006, 26-70.
Devarbhavi H, Asrani SK, Arab JP et al. Global burden of liver disease: 2023 update. J Hepatol. 2023 Aug;79(2):516-537. doi: 10.1016/j.jhep.2023.03.017. Epub 2023 Mar 27.
Попов Г. Дроги и превенция. Първо издание, 2000-2002.
Принципи на лечението на зависимостите. Наръчник, базиран на научни изследвания. Национален център по наркомании. Национален център по здравеопазване.
Bevan G. Problem drug use the health imperative: what some of the literature says. Subst Abuse Treat prev Poicy. 2009; 4:21. Doi: 10.1186 / 1747-597X-4-21.
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015 : a novel analysis from the Global Burden of Disease Study 2015. The Lancet. 2017, 390 (10091), 231-266. DOI: http://dx.doi.org/10.1016/S0140-6736 (17) 30818-8.
Hickmann M, Carnath Z, Madden P et al. Drug related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London. Journal of urban health: bulletin of the New York Academy of Medicine. June 2003; 80:274-287.
Le Moal M, Koob GF. Drug addiction: Pathways to the disease and pathophysiological perspectives. European Neuropsychopharmacology. 2007; 17:377-393.
Yellow List: List of Narcotic Drugs Under International Control. International Narcotics Control Board. Annex to Forms A, B and C, 50th edition, December 2011.
Bevan G. Problem drug use the health imperative: what some of the literature says. Subst Abuse Treat Prev Policy. 2009; 4: 21. Doi: 10.1186 / 1747-597X-4-21.
Национален център по наркомании – официален сайт. https://www.nfp-drugs.bg/
Chayasirisobhon S. Mechanisms of Action and Pharmacokinetics of Cannabis. Perm J. 2020 Dec;25:1-3. doi: 10.7812/TPP/19.200.
Zuardi AW. History of cannabis as a medicine: A review. Braz J Psychiatry, 2006 Jun;28:153-7. DOI: 10.1590/s1516-44462006000200015.
Maselli DB et al. Pharmacology, clinical effects, and therapeutic potential of cannabinoids for gastrointestinal and liver diseases. Clinical Gastroenterology and Hepatology. September 2021, 19(9), 1748-1758.e2.
Hindley G et al. Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. The Lancet Psychiatry, 7(4), 344-353.
Kroon E, Kuhns L, Cousijn J. The short-term and long-term effects of cannabis on cognition: recent advances in the field. Current Opinion in Psychology. April 2021, 38, 49-55.
Garry A, Rigourd V, Amirouche A et al. Cannabis and breastfeeding. J Toxicol, 2009;2009:596149. DOI: 10.1155/2009/596149.
Camilleri M, Zheng T. Cannabinoids and the Gastrointestinal Tract. Clinical Gastroenterology and Hepatology. December 2023, 21, (13), 3217-3229. https://doi.org/10.1016/j.cgh.2023.07.031
Dziemitko S, Harasim-Symbor E, Chabowski A. How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases. Therapeutic Advances in Chronic Disease. 2023;14. doi:10.1177/20406223221143239.
Joshi N, Onaivi ES. Endocannabinoid system components: overview and tissue distribution. Adv Exp Med Biol, 2019; 1162: 1-12.
Rajesh M, Bátkai S, Kechrid M et al. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes 2012; 61: 716-727.
Patsenker, Stickel E, Felix MD. Cannabinoids in liver diseases. Clinical Liver Disease. February 2016. 7(2):p 21-25. DOI: 10.1002/cld.527.
Mboumba Bouassa R-S, Sebastiani G, Di Marzo V et al. Cannabinoids and Chronic Liver Diseases. International Journal of Molecular Sciences. 2022; 23(16):9423. https://doi.org/10.3390/ijms23169423
Avraham Y, Ilan Y, Israeli E, Berry EM. Endocannabinoids and liver disease-Review. Liver Int. 2005, 25, 921-926.
Adejumo AC, Alliu S, Ajayi TO et al. Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study. PLoS ONE. 2017;12:e0176416. doi: 10.1371/journal.pone.0176416.
Rajavashisth TB, Shaheen M, Norris KC et al. Decreased prevalence of diabetes in marijuana users: Cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III. BMJ Open. 2012;2:e000494. doi: 10.1136/bmjopen-2011-000494.
Whitfield JB, Masson S, Liangpunsakul S et al. Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers. Am J Gastroenterol. 2021;116:106-115. doi: 10.14309/ajg.0000000000000833.
Hézode C, Roudot-Thoraval F, Nguyen S et al. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology. 2005 Jul;42(1):63-71. doi: 10.1002/hep.20733. Erratum in: Hepatology. 2005 Aug;42(2):506. Pawlostky, Jean-Michel [corrected to Pawlotsky, Jean-Michel].
Gingrich J, Choudhuri S, Cournoyer P et al. Review of the oral toxicity of cannabidiol (CBD). Food and Chemical Toxicology. June 2023, 176, 113799.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 D. Lyubomirova, А. Grigorian (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.
Journal Bulgarian Medical Journal (Български медицински журнал / Bulgarian Medical Journal)
